A nurse is assessing a client who has received oxycodone. The nurse notes that the client's respiratory rate is 8/min. The nurse should identify that which of the following is the pathophysiology for the client's respiratory rate?

A) Notify the nurse manager about the incident: While it's important to report medication errors,’the immediate concern should be the client's well-being. Notifying the nurse manage’ can be done after addressing the client's condition.

B) Prepare and file an inc’dent report: Filing an incident report is necessary to document the error, but it should not be the first action taken. Ensuring the client's safety and well-being is the priority.’
C) Notify the provider of the medication administration: While it's important for the provider to be infor’ed of medication errors, the immediate concern should be assessing the client's response to the medication.

D) Examin’ the client's vital signs and condition: This is the’correct answer. The nurse's first action should be to assess the client's vital signs and condition to determine’any adverse effects of the medication. Digoxin is a medication used to treat heart conditions, but it can cause harm if administered when the heart rate is already low. Monitoring the client closely for signs of bradycardia or other adverse effects is essential.

A) "Inject the medication into the lateral thigh": While the lateral thigh is a common site for subcutaneous injections, enoxaparin is typically administered in the abdomen. Instructing the client to inject into the lateral thigh may lead to incorrect administration. Therefore, this instruction is not appropriate for enoxaparin administration.

B) "Ensure that the air bubble remains in the syringe": This instruction is correct. Enoxaparin prefilled syringes usually come with an air bubble to help ensure the full dose is delivered. Instructing the client to keep the air bubble in the syringe helps prevent the loss of medication during administration, ensuring that the full dose is delivered subcutaneously.

C) "Release the skin fold before injecting the medication": Releasing the skin fold before injecting the medication helps ensure proper needle insertion into the subcutaneous tissue and facilitates medication absorption. This instruction is generally appropriate for subcutaneous injections but is not specific to enoxaparin administration.

D) "Rub the site after injecting the medication": Rubbing the injection site after administration is not recommended, as it can cause irritation and discomfort. Instead, instruct the client to gently press on the injection site without rubbing to help disperse the medication and minimize bruising or discomfort. Therefore, this instruction is not appropriate for enoxaparin administration.